BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmacology - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.med.unc.edu/pharm
X-WR-CALDESC:Events for Pharmacology
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260609T160000
DTEND;TZID=America/New_York:20260609T170000
DTSTAMP:20260612T222715
CREATED:20260603T180214Z
LAST-MODIFIED:20260603T180214Z
UID:10001065-1781020800-1781024400@www.med.unc.edu
SUMMARY:Dr. Samantha Bevill of Dana-Farber Cancer Institute presents
DESCRIPTION:THIS SEMINAR HAS BEEN POSTPONED \nSamantha Bevill\, PhD\nDana-Farber Cancer Institute and Broad Institute of MIT and Harvard \nSeminar title: “From Transcriptional Rewiring to Therapeutic Opportunities: Targeting MDM2 Amplifications in Cancer” \nLocation: 4007 Genetic Medicine Building \nPlease join us and show support for our seminar speakers!\n(For those unable to attend\, a zoom link is available upon request to Mimi Baltz.) \nHost: UNC Lineberger & Pharmacology Special Seminar Series \nAbout Dr. Bevill: Samantha Bevill\, PhD\, is a pharmacologist specializing in the mechanisms of therapeutic resistance in aggressive cancers. She earned her B.S. in Microbiology from Clemson  university and her Ph.D. in Pharmacology from the University of North Carolina at Chapel Hill. Under the mentorship of Dr. Gary Johnson\, her doctoral research utilized advanced proteomics and genomics to map compensatory kinase signaling pathways in breast \ncancer. Currently\, as a postdoctoral fellow in Dr. Bradley Bernstein’s laboratory\, Dr. Bevill investigates the transcriptional regulatory landscapes of aggressive sarcomas. Her work has uncovered a novel role for MDM2 in driving therapeutic resistance. Dr. Bevill’s most recent work\, which is co-advised by Dr. Jun Qi\, bridges basic mechanistic \ndiscovery and therapeutic application\, developing chemical biology strategies to leverage MDM2’s E3 ligase activity for tumor-specific protein degradation.
URL:https://www.med.unc.edu/pharm/event/dr-samantha-bevill-of-dana-farber-cancer-institute-presents/
LOCATION:4007 Genetic Medicine Building\, 120 Mason Farm Rd\, Chapel Hill\, North Carolina\, 27514\, United States
CATEGORIES:Pharmacology Seminars
ATTACH;FMTTYPE=image/jpeg:https://www.med.unc.edu/pharm/wp-content/uploads/sites/930/2026/06/Flyer_Postpned-Sam-Bevil-464.jpg
ORGANIZER;CN="Mimi Baltz":MAILTO:my.le@unc.edu
END:VEVENT
END:VCALENDAR